GSK3B and hepatocellular carcinoma: Thus, we concluded that BS‐I inhibits migration and invasion of HCC cell by suppressing AKT/GSK‐3β/β‐catenin pathway, because MEK1/2 and ERK1/2 are also regulated by of AKT 32.